US Stocks
/
MacroGenics, Inc. Share Price

MacroGenics, Inc. Share Price

NASDAQ: MGNX | Micro Cap
$3.75
+$0.19 (5.34%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

MacroGenics, Inc. Stock Performance

Open
$3.57
Prev. Close
$3.56
Circuit Range
N/A
Day Range
$3.57 - $3.79
Year Range
$1.29 - $5.07
Volume
36,168
Average Traded
$3.73

MacroGenics, Inc. Share Price Today

As of 11 October 2026, MacroGenics, Inc.'s share price is $3.75. The stock opened at $3.57, compared to its previous close of $3.56. During today's trading session, MacroGenics, Inc.'s share price traded between $3.57 and $3.79, with an average price of $3.68. Over the past 52 weeks, the stock has recorded a high of $5.07 and a low of $1.29. In terms of performance, MacroGenics, Inc.'s share price has risen by 22.15% over the last six months and is up 127.27% on a year-on-year basis.

MacroGenics, Inc. Share Price Chart

$3.57$3.79
L
Show Current Price
H

MacroGenics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$236.83M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.23
Revenue (TTM)
$149.50B
Return On Equity (TTM)
-34.17%
Profit Margin
-49.91%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
16.05%

MacroGenics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$72.84$41.23$20.78$32.83
Net Profit$16.82-$14.16-$36.83$19.52
Net Profit Margin23.09%-34.34%-177.24%59.46%
Income ChangeN/A-184.19%-160.10%153.00%

MacroGenics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$151.94$58.75$149.96$149.50
Net Profit-$119.76-$9.06-$66.97-$74.62
Net Profit Margin-78.82%-15.42%-44.66%-49.91%
Income ChangeN/A92.43%-639.18%-11.42%

About MacroGenics, Inc.

Macrogenics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of cancer. The company is currently developing therapeutics utilizing multiple modalities, including antibody-drug conjugates (ADCs) and multi-specific antibodies (which it refers to as DART and TRIDENT molecules). It is advancing three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload. Its segment is developing and commercializing monoclonal antibody-based therapeutics.

MacroGenics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$3.78
$3.73
-3.37%
Sep 2026
$3.94
$3.85
-5.51%
Aug 2026
$3.72
$4.08
+10.42%
Jul 2026
$4.71
$3.69
-20.11%
Jun 2026
$4.12
$4.63
+10.65%
May 2026
$3.03
$4.18
+36.16%
Apr 2026
$2.95
$3.07
+6.41%
Mar 2026
$1.98
$2.88
+44.97%
Feb 2026
$1.83
$1.99
+8.45%
Jan 2026
$1.58
$1.83
+13.27%
Dec 2025
$1.48
$1.62
+5.19%
Nov 2025
$1.67
$1.54
-6.67%

MGNX Share Price FAQs

What is MacroGenics, Inc. share price today?

chevron-up
MacroGenics, Inc. share price today is $3.75 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of MacroGenics, Inc. stock?

chevron-up
The 52 week high of MacroGenics, Inc. stock is $5.07, while the 52 week low is $1.29 as of 10 Oct '26.

What is MGNX's market capitalisation today?

chevron-up
MGNX market capitalisation is $236.83M as of October 11, 2026, at 9:32 am IST.

What is MGNX's net income for the last quarter?

chevron-up
MGNX's net income for the last quarter is 19.52B USD.

What is the 5 year returns of MGNX?

chevron-up
The 5 year returns of MGNX is -80.80% as on 10 Oct '26.

What is the high & low stock price of MGNX today?

chevron-up
MGNX stock price hit a high of $3.79 and low of $3.57 as of 10 Oct '26.

Can I buy MGNX shares in India?

chevron-up
Yes. You can buy MGNX in India by opening an international trading account.